Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason P Appleton

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Stroke|December 1, 2021
Effects of Cilostazol and Isosorbide Mononitrate on Cerebral Hemodynamics in the LACI-1 Randomized Controlled TrialGordon W Blair, Esther Janssen, Michael S Stringer, et al.
Scientific Reports|July 20, 2023
Bleeding with intensive versus guideline antiplatelet therapy in acute cerebral ischaemiaLisa J Woodhouse, Jason P Appleton, Hanne Christensen, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 2, 2017
Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053)Jason P Appleton, Polly Scutt, Mark Dixon, et al.
Stroke|January 11, 2019
Effect of Glyceryl Trinitrate on Hemodynamics in Acute StrokeJason P Appleton, Lisa J Woodhouse, Daniel Bereczki, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 15, 2017
Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combinationGordon W Blair, Jason P Appleton, Zhe Kang Law, et al.
Eclinicalmedicine|July 19, 2019
Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trialGordon W Blair, Jason P Appleton, Katie Flaherty, et al.
Neurology|December 29, 2019
Imaging markers of small vessel disease and brain frailty, and outcomes in acute strokeJason P Appleton, Lisa J Woodhouse, Alessandro Adami, et al.
Eclinicalmedicine|February 3, 2022
Effect of continuing versus stopping pre-stroke antihypertensive agents within 12 h on outcome after stroke: A subgroup analysis of the efficacy of nitric oxide in stroke (ENOS) trialLisa J Woodhouse, Jason P Appleton, Polly Scutt, et al.
BMJ Neurology Open|August 11, 2023
Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): effects on outcomes at day 365 in a randomised, sham-controlled, blinded, phase III, superiority ambulance-based trialLisa J Woodhouse, Jason P Appleton, Sandeep Ankolekar, et al.
Stroke|November 19, 2019
Noncontrast Computed Tomography Signs as Predictors of Hematoma Expansion, Clinical Outcome, and Response to Tranexamic Acid in Acute Intracerebral HemorrhageZhe Kang Law, Azlinawati Ali, Kailash Krishnan, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Stroke|December 1, 2021
Effects of Cilostazol and Isosorbide Mononitrate on Cerebral Hemodynamics in the LACI-1 Randomized Controlled TrialGordon W Blair, Esther Janssen, Michael S Stringer, et al.
Scientific Reports|July 20, 2023
Bleeding with intensive versus guideline antiplatelet therapy in acute cerebral ischaemiaLisa J Woodhouse, Jason P Appleton, Hanne Christensen, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 2, 2017
Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053)Jason P Appleton, Polly Scutt, Mark Dixon, et al.
Stroke|January 11, 2019
Effect of Glyceryl Trinitrate on Hemodynamics in Acute StrokeJason P Appleton, Lisa J Woodhouse, Daniel Bereczki, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 15, 2017
Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combinationGordon W Blair, Jason P Appleton, Zhe Kang Law, et al.
Eclinicalmedicine|July 19, 2019
Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trialGordon W Blair, Jason P Appleton, Katie Flaherty, et al.
Neurology|December 29, 2019
Imaging markers of small vessel disease and brain frailty, and outcomes in acute strokeJason P Appleton, Lisa J Woodhouse, Alessandro Adami, et al.
Eclinicalmedicine|February 3, 2022
Effect of continuing versus stopping pre-stroke antihypertensive agents within 12 h on outcome after stroke: A subgroup analysis of the efficacy of nitric oxide in stroke (ENOS) trialLisa J Woodhouse, Jason P Appleton, Polly Scutt, et al.
BMJ Neurology Open|August 11, 2023
Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): effects on outcomes at day 365 in a randomised, sham-controlled, blinded, phase III, superiority ambulance-based trialLisa J Woodhouse, Jason P Appleton, Sandeep Ankolekar, et al.
Stroke|November 19, 2019
Noncontrast Computed Tomography Signs as Predictors of Hematoma Expansion, Clinical Outcome, and Response to Tranexamic Acid in Acute Intracerebral HemorrhageZhe Kang Law, Azlinawati Ali, Kailash Krishnan, et al.
Pageof 6